Status:
COMPLETED
Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants
Lead Sponsor:
Sharp HealthCare
Conditions:
Atelectasis Neonatal
Pneumothorax and Air Leak
Eligibility:
All Genders
Brief Summary
To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography
Detailed Description
To quantify the changes in regional lung air content associated with the variations of the respiratory support settings, the following approach will be used. The changes in local air content will be d...
Eligibility Criteria
Inclusion
- All infants admitted to the NICU at SMBHWN
- Informed consent obtained
- Atelectasis confirmed on CXR
- Pneumothorax confirmed on CXR
Exclusion
- Declined consent
- Infants with known congenital anomalies
Key Trial Info
Start Date :
August 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 7 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04848727
Start Date
August 6 2021
End Date
June 7 2022
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sharp Mary Birch Hospital for Women & Newborns
San Diego, California, United States, 92123